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Background: MicroRNAs are non-coding RNAs involved in the regulation of gene expression including DNA
damage responses. Low doses of low energy X-ray radiation, similar to those used in mammographic exams, has
been described to be genotoxic. In the present work we investigated the expression of miR-34a; a well described
p53-regulated miRNA implicated in cell responses to X-ray irradiation at low doses.
Methods: Non-cancerous breast cell line MCF-10A and cancerous T-47D and MCF-7 cell lines were submitted to a
low-energy X-ray irradiation (ranging from 28–30 Kv) using a dose of 5 Gy. The expression level of miR-34a, let-7a
and miR-21 was assessed by qRT-PCR at 4 and 24 hours post-irradiation. DNA damage was then measured by
comet assay and micronuclei estimation in MCF-10A and MCF-7 cell lines, where an increase of miR-34a levels
could be observed after irradiation. The rate of apoptotic cells was estimated by nuclear staining and fluorescence
microscopy. These experiments were also performed at low doses (3; 12 and 48 mGy) in MCF-10A and MCF-7 cell
lines.
Results: We have observed an increase in miR-34a expression 4 hours post-irradiation at 5 Gy in MCF-10A and
MCF-7 cell lines while its level did not change in T-47D, a breast cancer cell line bearing non-functional p53. At low
doses, miR-34a was up-regulated in non-tumoral MCF-10A to a higher extent as compared to MCF-7. MiR-34a levels
decreased 24 hours post-irradiation. We have also observed DNA damage and apoptosis at low-energy X-ray
irradiation at low doses and the high dose in MCF-10A and MCF-7 4 and 24 hours post-irradiation relative to the
mock control.
Conclusion: Low energy X-ray is able to promote DNA strand breaks and miR-34a might be involved in cell
responses to low energy X-ray DNA damage. MiR-34a expression correlates with X-ray dose, time after irradiation
and cell type. The present study reinforces the need of investigating consequences of low dose X-ray irradiation of
breast cells.
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MicroRNAs (miRNAs) constitute a class of evolutionar-
ily conserved small non-coding RNAs which regulates
gene expression at the post-transcriptional level. They
were at first assigned to target complementary sequences
in the 3′UTR of mRNAs, only requiring a continuous
base-pairing of miRNA nucleotides 2 to 8, known as the
seed sequence to subsequently direct mRNAs for trans-
lational inhibition and decay [1]. Later, recognition sites
located outside 3′UTR have been observed by computa-
tional tools and validated by functional approaches [2,3],
rendering these small RNAs to be involved in the regula-
tion of virtually all cellular processes [4,5]. The global
action of miRNAs is to repress gene expression and, by
this way, they are involved in important cellular pro-
cesses including DNA damage response (DDR) [6,7].
Ionizing radiation such as X-rays can harm cells by dir-
ect DNA breakage or indirectly through the creation of
free radicals which will contribute to increase and pro-
long DNA damage [8]. Increasing evidence indicates that
such injurious effects are not linear with the radiation
dose mainly due to different cellular mechanisms to
adapt or die, which are highly dependent on cell type
and cell environmental conditions [8]. Hence, irradiated
cells may activate DNA repair system or apoptosis. Ini-
tial cell responses to genotoxic stress occur through mo-
lecular sensors, usually kinases that trigger DDRs. For
example, the ATM-mediated DDR activates the tumor
suppressor protein p53, a transcription factor critical for
genomic stability, regulating cell cycle progression and
DNA repair, as well as apoptosis. In this same sense, it is
expected that miRNAs are involved in mechanisms such
those regulated by p53 [9,10]. Apoptosis and DNA repair
are intricately connected with DNA damage and cancer.
Irradiation leads to a massive change in miRNA expres-
sion pattern [11,12], unfortunately the roles of specific
miRNAs in radiation response are not yet clearly iden-
tified. We decided to concentrate on three miRNAs,
miR-34a, let-7a and miR-21 since they are consistently
associated with the modulation of cell damage response
pathways [13]. MiR-34a is a direct p53 target gene and
its ectopic expression induces apoptosis, cell-cycle arrest
in G1 or senescence [14]. In vitro experiments using
C elegans and breast cancer cells as models showed that
loss of function mutations in miR-34a gene generated an
abnormal cellular survival response to radiation [15].
Validated miR-34a targets include several genes involved
in DDR as Bcl-2, Notch1, Cyclin D1, Cyclin E2, CDK4,
MET and SIRT1 [16-18], suggesting that miR-34a may
serve as a marker of radiation injury and as a therapeutic
target [14,19]. Let-7a is a member of a family which
comprises 12 miRNAs with tumor suppressor activities
that can be regulated in response to ionizing radiation.
Among let-7a targets there are molecules involved insuch important cellular activities as proliferation (K-ras;
c-myc; E2F2) and cell cycle control (Cdc25a; Cyclin D1).
Let-7a is usually down-regulated after ionizing radiation
exposure, however its overexpression can increase radio-
sensitivity in vivo and in different tumor types mainly by
downregulation of K-Ras [20,21]. Finally, miR-21, clas-
sified as an oncogenic miRNA, was described as a ne-
gative regulator of some suppressor genes related to
proliferation, apoptosis and invasion such as PTEN,
PDCD4, Tropomyosin-1 and Bcl-2 [22-24]. MiR-21 is
often up-regulated in tumors and its overexpression
is associated with a more proliferative and aggressive
phenotype [25]. In vivo and in vitro studies suggest a role
for miR-21 in tumor initiation and progression and as a
possible diagnostic and prognostic marker for human ma-
lignancies. In breast cancer, miR-21 knockdown cells can
trigger apoptotic cell death followed by a decrease in cell
proliferation suggesting a function as anti-apoptotic factor
[26]. MiR-21 is usually up-regulated after irradiation and
its inactivation can contribute to radiation induced apop-
tosis [27,28]. Several miRNAs with aberrant expression
are present ubiquitously in breast and other cancers.
Microarray analysis shows a global change in miRNA ex-
pression in the presence of genotoxic agents including
ionizing radiation [29]. To test the hypothesis that miR-
34a is involved in the DDR after X-ray irradiation of breast
cells, we determined relative expression of miR-34a, let-7a
and miR-21, in the non-cancerous breast cell line MCF-
10A and the breast cancer cell lines MCF-7 and T47-D, 4
and 24 hours after X-ray exposure at a high dose (5 Gy).
We have also applied X-ray irradiation doses rate and en-
ergy equivalent to those utilized in mammographic exams,
usually 10 mGy/s for 28 kV [30] in breast cells MCF-10A
and MCF-7. Our results show an overexpression of miR-
34a in the non-cancerous MCF-10A cells in response to
DNA damage caused by low-doses of X-ray radiation.
Materials and methods
Cell culture
The human breast adenocarcinoma cell line MCF-7, the
ductal carcinoma cell lineT-47D and the non-cancerous epi-
thelial breast cell line MCF-10A were obtained from David
Cappellen and Nancy Hynes (Friedrich Miescher Institute
for BioMedical Research, Novartis Research Foundation,
Basel, Switzerland). The MCF-7 and T-47D cells were cul-
tured in RPMI 1640 supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin, streptomycin. MCF-10A cells
were maintained in DMEM/F12 supplemented with 10%
FBS, hydrocortisone 0.5 μg/mL, insulin 10 μg/mL, EGF
20 ng/mL and 1% penicillin, streptomycin. The culture
medium and FBS were purchased from Life Technologies
(Carlsbad, CA, USA), all others supplements were from
Sigma Aldrich (St Louis, MO, USA). Cultures were routinely
checked for mycoplasma contamination.
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Cells in the logarithmic growth phase were submitted to
X-ray irradiation with a Philips X-ray tube (PW 2185/00
Side window) with Mo anode and 0.03 mm Mo filter,
employed in mammography dosimeters calibration. After
irradiation at 3; 12 and 48 mGy/28 kV and 5 Gy/30 kV,
the cells were incubated for 4 and 24 hours in cultured
medium, at 37°C, under 5% of CO2. A mock control
performed with cells under the same conditions but the
irradiation was added in all experiments.
Comet assay (single cell electrophoresis assay)
Alkaline comet assay was performed according to the
method described elsewhere [31] with modifications.
Aliquots containing 2.5 x 105 cells were pelleted and
resuspended in 10 μL of PBS 1X (60 mM NaCl; 0.2 mM
KCl; 0.1 mM Na2HPO4; 0.1 mM KH2PO4, pH 7.4).






















































Figure 1 Single cell electrophoresis assay performed after 4 and 24 h
0.048 Gy/28 kV and 5 Gy/30 kV. The percentage of DNA strand breaks o
MCF-7 was analyzed according to the length and thickness of comet tail a
intensities. The percentage of tail DNA was assigned by summing the total
category number. Total analyzed cells per slide 100. (C) Example of silver st
lesion type 2 (2, 3) * significant difference in comparison irradiated versus n
showing the percentage of cells detected in each category of damage. † C
categories 1 to 4 represents increasing amounts of DNA breaks. DS stands
tail DNA.at 37°C were added to these cell aliquots and then im-
mediately distributed on glass slides previously covered
with a thin layer of 1.5% normal melting point agarose.
After upper agarose solidification, the slides were trans-
ferred to a lysis solution (2.5 M NaCl; 10 mM Tris;
100 mM EDTA; 10% DMSO; 1% lauryl sarcosinate; 1%
triton X-100; pH 10) at 4°C for 12 h and kept on electro-
phoresis alkaline buffer (0.3 M NaOH; 1 mM EDTA;
pH 13) for 20 minutes before running electrophoresis at
25 V/300 mA for 20 minutes. After electrophoresis, DNA
was silver stained according to [32,33]. A total of 100 cells
were analyzed per slide and visually classified into four cat-
egories according to the degree of DNA damage, where 0
corresponds to no damage and 4 to a highly damaged DNA.
The percentage of tail DNA was assigned by summing the
total number of cells containing tail DNA, multiplied by its
respective category number. All experiments were per-








ours incubation on X-ray irradiated cells at 0.003; 0.012;
bserved in the mammary epithelial cell lines (A) MCF-10A and (B)
nd classified into four categories from 1–4 representing increasing tail
number of cells containing tail DNA, multiplied by its respective
ained of a nuclei with no visible lesion (1) and a tail DNA classified as
on-treated cells (Student’s t test * P≤ 0.05; ** P≤ 0.001). (D) Table
omet tail type: 0 corresponds for no visible DNA breaks and the
for Damage Score and corresponds to the total percentage of
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For apoptosis and micronuclei estimation, MCF-10A and
MCF-7 cells were cultured as described before. Cells were
submitted to a 3; 12 and 48 mGy/28 kV and 5 Gy/30 kV
X-ray irradiation and incubated for 4 and 24 hours, at
37°C, under 5% of CO2. Then, cells were collected and the
evaluation of nuclei morphology was performed by fluor-
escence microscopy, using HOECHST 33258 staining.
The micronuclei assay was done based on Kirsch-Volders
et al. [34]. The number of apoptotic and micronucleated
cells was scored for each condition. A total of 100 nuclei
were counted per slide. All experiments were performed
in triplicate and repeated at least two times.
RNA extraction and quantitative RT-PCR
Total RNA samples were obtained using Trizol reagent
(Life Technologies; Carlsbad, USA), according to the
manufacturer’s protocol. Reverse transcriptase reaction
and quantitative PCR were performed using NCode
VILO miRNA cDNA Synthesis Kit (Life Technologies;
Carlsbad, USA). Real-time PCR was done using SYBR
green reagents (Life Technologies; Carlsbad, USA). Pri-
mer sequences used in qPCR reaction were: β-actin(F)
5′-CATCGAGCACGGCATCGT-3′; β-actin(R) 5′-GCC











































Figure 2 Percentage of micronuclei formation, observed by fluoresce
MCF-7 cell lines 24 hours after 0.003; 0.012; 0.048 Gy/28 kV and 5 Gy/30 Kv
formed after irradiation. Paired t-test with 95% confidence intervals were p
comparison to its corresponding mock control. Student’s t test * P≤ 0.05.5′-CCGCTGAGGTAGTAGGTTGTATAGTT-3′; miR-21
(F) 5′-GGCTAGCTTATCAGACTGATGTTGA-3′; with
the universal reverse primer provided on miRNA cDNA
synthesis kit. The reaction conditions were as following:
denaturing at 95°C for 2 min and 40 cycles of denaturing
at 95°C for 15 sec and annealing at 60°C for 60 sec
followed by a melting curve. All experiments were done in
triplicate and repeated at least two times. Relative expres-
sion was analyzed using the ΔΔCt method [35,36].
Statistical analysis
All statistical analysis were performed on the irradiated
samples of each type of cell line in comparison to its
corresponding mock control using paired t-test with
95% confidence intervals.
Results
To estimate DNA damage in different X-ray doses we
first performed the comet assay with irradiated non-
cancerous breast cells MCF-10A and cancerous MCF-7
cells, using low-energy (28/30 kV) X-ray irradiation at
low doses (3; 12 and 48 mGy) and at a high dose (5 Gy).
As shown in Figure 1, DNA lesions were observed at all
applied doses 4 hours after irradiation. MCF-10A
presented a higher level of DNA lesions, approximately





nt microscopy (1000x) after Hoechst staining. (A) MCF-10A and (B)
X-ray irradiation. (C) Example of a cell containing a micronucleus
erformed on the irradiated samples of each type of cell line in
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DNA strand breaks was observed in MCF-7 but not in
MCF-10A (Figure 1A and B). Both cell lines showed low
levels of micronucleated cells at all analyzed irradiation
conditions and time points, with MCF-10A cells show-
ing almost no detectable micronuclei. MCF-7 cells
presented approximately 5% of micronucleated cells at
24 hours after irradiation with 5 Gy, the highest dose
(Figure 2A and B). Nevertheless, we could detect the oc-
currence of apoptotic cells in both cell lines at 4 and
24 hours after irradiation, although neither dose- nor
time-dependent (Figure 3A and B). We have next
performed qRT-PCR in order to detect alterations in
miR-34a, let-7a and miR-21 known to be involved in
DDR [13]. We have first used a high dose (5 Gy) to ir-
radiate cells and we observed that miR-34a was the most
up-regulated one, with approximately increase of 13
times fold change in MCF-10A and 9 times fold-change
in MCF-7, 4 hours after 5 Gy X-ray irradiation (Figure 4
A-C). At 24 hours, miR-34a levels lowered, relative to
the expression observed at 4 hours, showing an approxi-
mately 4 times fold-change when compared to the non-
treated control, in both cell lines. We also investigated
the miRNAs expression levels in T-47D cell line and the
miR-34a expression was not altered (Figure 4A). We






































Figure 3 Percentage of cells containing apoptotic features, observed
MCF-10A and (B) MCF-7 cell lines 4 and 24 hours after 0.003; 0.012; 0.048 G
cell displaying a perturbation in its nuclear envelope. Paired t-test with 95%
each type of cell line in comparison to its corresponding mock control. (Stubreast cells in response to low doses of X-ray irradiation.
We have applied doses and energy equivalent to that
used in mammographic exams, approximately 10 mGy/
28 kV [30]. Therefore, we have irradiated exponentially
growing cells with doses 3; 12 and 48 mGy and quanti-
fied miR-34a expression at time points 4 and 24 hours.
As demonstrated in Figure 5A, miR-34a up-regulation is
clearly observed in MCF-10A cells at 4 hours after ir-
radiation in a dose-dependent fashion. Interestingly, with
MCF-7 this same effect is not observed (Figure 5B).
Since an important miR-34a up-regulation of 8 times
fold-change was detected in MCF-7 cells at a dose of
5 Gy (Figure 4A), our results suggest that in this cancer
cell line higher doses are necessary to induce miR34a
expression.
Discussion
Recent findings regarding the use of low-energy X-ray ra-
diation at low doses commonly employed in mammo-
graphic exams, indicate that such irradiation is potentially
more harmful to cells than considered by physicians. In
2004, Heyes and Mill [30], by relative biological effec-
tiveness studies (RBE), demonstrated that the low-energy
X-rays used in mammography (approximately 29 kV) in-
creased four-fold the risk of mutational DNA damage than






by fluorescent microscopy (1000x) after Hoechst staining. (A)
y/28 kV and 5 Gy/30 Kv X-ray irradiation (C) Example of an apoptotic
confidence intervals were performed on the irradiated samples of






















































































Figure 4 microRNA expression by qRT-PCR in MCF-10A, MCF-7
and T-47D cell lines, assessed 4 and 24 hours after 5 Gy/30 Kv
X-ray irradiation event. Relative expression of miRNAs (A) miR-34a,
(B) let-7a and (C) miR-21 was calculated by ΔΔCT method and the
acquired fold change values are relative to their respective
non-treated mock control. * significant difference in comparison


























































Figure 5 miR-34a expression by qRT-PCR in (A) MCF-10A and
(B) MCF-7cell lines, assessed 4 and 24 hours after X-ray
irradiation at 0.003; 0.012 and 0.048 Gy/28 Kv conditions.
Relative expression of miR-34a was calculated by ΔΔCT method and
the acquired fold change values are relative to their respective
non-treated mock control. * significant difference in comparison
irradiated versus non-treated cells (Student’s t test P≤ 0.05).
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X-rays are underestimated by the same factor. The bio-
logical effects caused by ionizing radiation are explained
by two phenomena: one of a direct target hit, where the
nuclear DNA is the major target molecule and the other
by non-targeted effects or indirect actions of radiation.
Low doses at low-energy radiation are characterized by a
high indirect activity through reactive oxygen species gen-
eration and bystander effects. These effects persist for long
periods, whereas DNA breaks induced by direct radiationare repaired relatively quickly [8,30,37]. Therefore, both
direct and indirect ionizing radiation effects result in DNA
damage and in DNA damage cell responses (DDRs) [38].
MicroRNAs have been described as a class of regulatory
molecules which can modulate cell physiology and are
associated to several pathways including G1 arrest, DNA
repair and apoptosis. They have been also described to be
induced by X-rays evoking a role of intermediate mole-
cules in the regulation of DDRs [39,40]. Due to the wide-
spread utilization of mammographic exams, the possible
relationship between miRNAs expression and DNA dam-
age caused by low energy, low-dose X-ray irradiation is an
important matter of study. We have designed experiments
to first demonstrate the presence of DNA lesions during
low energy, low-dose X-ray irradiation of mammary cells
in culture and then proceed to the determination of
miRNAs expression in these conditions. Comet assay and
micronuclei estimation were performed after irradiation
with the cells MCF-10A and MCF-7, a non-cancerous and
a cancerous cell line, respectively. The comet assay per-
mits to detect DNA single-strand breaks, alkali-labile sites
and double strand breaks associated with incomplete exci-
sion repair sites [31] while the micronuclei detects the
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though not linearly related to the applied doses, at 4 hours
after X-ray irradiation with 3; 12 and 48 mGy/28 kV and
5 Gy/30 kV doses, an increase in DNA lesions was clearly
observed in the comet assay. Moreover, the cell line MCF-
10A presented higher levels of DNA breaks than MCF-7
cells. At 24 hours, however, MCF-10A cells apparently re-
covered DNA integrity, at least at low doses, while MCF-7
presented persistent DNA lesions. This is in agreement
with the data of Francisco et al., 2008 [42] who demon-
strated that MCF-7 cells tend to accumulate more DNA
lesions than MCF-10A after γ-radiation exposure. We
then analyzed the expression levels of three miRNAs:
miR-34a, let-7a and miR-21. The miR-21 is considered an
oncogenic miRNA and is frequently over-expressed in sev-
eral types of cancer; conversely, let-7a and miR-34a func-
tion as tumor suppressors and are frequently down-
regulated in cancer. MiR-34 family expression is induced
by p53 which is a key protein regulating different forms of
cellular stress, including X-ray irradiation [43]. Among the
analyzed miRNAs, miR-34a showed to be the most over-
expressed after 5Gy irradiation in both MCF-10A and
MCF-7 cells. MiR-34a expression was also measured after
the low-dose irradiation in MCF-10A and MCF-7 cell
lines. Interestingly miR-34a expression appears to correl-
ate with the applied dose and the apoptosis level in MCF-
10A. Hence, this miRNA might act as an irradiation bio-
marker in normal cells. MCF-7 cells presented a signifi-
cant miR-34a up-regulation at the lower dose 3 mGy.
Some cell lines have been observed to exhibit hypersensi-
tivity to low radiation doses [44]. Although the direct ef-
fect of radiation in the hit DNA molecule is proportional
to the dose, effects occurring in non-targeted molecules
cannot be predicted in a dose–response fashion. Usually,
the enhanced sensitivity at low doses of ionizing radiation
reflects the failure of the repair machinery to fully arrest
the progression of the cell cycle, preventing unrepaired
DNA breaks, from undergoing cell division [44]. This may
be the case with the MCF-7 cells.
Women at high risk of breast and ovarian cancers are
usually more susceptible to radiation-induced cancer be-
cause most of tumor suppressor genes implicated in breast
cancer susceptibility are also implicated in the radio-
induced DNA damage repair and signaling such as BRCA1/
2,TP53 and ATM [45,46]. The results of a European cohort
study associates diagnostic radiation before the age of 30
with an increased risk of breast cancer among BRCA1/2
mutation carriers [47]. Unfortunately, this is the group of
women most exposed to low energy radiation, since they
are subject to annual prophylactic screening by the age of
30–35, while in the rest of population, mammography is
recommended at age 40 [48]. Our observations may help to
understand the effects of low energy X-ray irradiation in
healthy women and breast cancer patients.Conclusion
Our results indicate that miR-34a is up-regulated after
X-ray irradiation in P53 positive normal and cancer
breast cell lines. MiR-34a might be involved in breast
cell responses to low dose X-ray DNA damage. The
present study reinforces the need of investigating conse-
quences of low dose X-ray irradiation of breast cells.
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